Displaying 1 - 12 of 12
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
1

Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
1

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
1

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey - ILC 2022

View
Displaying 1 - 12 of 12